Cargando…

Aminoacylase 3 Is a New Potential Marker and Therapeutic Target in Hepatocellular Carcinoma

Ras proteins (HRas, KRas and NRas) are common oncogenes that require membrane association for activation. Previous approaches to block/inhibit Ras membrane association were unsuccessful for cancer treatment in human clinical studies. In the present study we utilized a new approach to decrease Ras me...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tsirulnikov, Kirill, Duarte, Sergio, Ray, Anamika, Datta, Nakul, Zarrinpar, Ali, Hwang, Lin, Faull, Kym, Pushkin, Alexander, Kurtz, Ira
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2018
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5743706/ https://www.ncbi.nlm.nih.gov/pubmed/29290764 http://dx.doi.org/10.7150/jca.21747

Ejemplares similares

Single Particle Electron Microscopy Analysis of the Bovine Anion Exchanger 1 Reveals a Flexible Linker Connecting the Cytoplasmic and Membrane Domains
por: Jiang, Jiansen, et al.
Publicado: (2013)

Correction: Single Particle Electron Microscopy Analysis of the Bovine Anion Exchanger 1 Reveals a Flexible Linker Connecting the Cytoplasmic and Membrane Domains
por: Jiang, Jiansen, et al.
Publicado: (2013)

CryoEM structure of the human SLC4A4 sodium-coupled acid-base transporter NBCe1
por: Huynh, Kevin W., et al.
Publicado: (2018)

Current Trends in Surgical Management of Hepatocellular Carcinoma
por: Angeli-Pahim, Isabella, et al.
Publicado: (2023)

Cryo-EM structure of the sodium-driven chloride/bicarbonate exchanger NDCBE
por: Wang, Weiguang, et al.
Publicado: (2021)

Publisher Correction: Cryo-EM structure of the sodium-driven chloride/bicarbonate exchanger NDCBE
por: Wang, Weiguang, et al.
Publicado: (2021)

CryoEM structures of anion exchanger 1 capture multiple states of inward- and outward-facing conformations
por: Zhekova, Hristina R., et al.
Publicado: (2022)

Expressional divergence of the fatty acid-amino acid conjugate-hydrolyzing aminoacylase 1 (L-ACY-1) in Helicoverpa armigera and Helicoverpa assulta
por: Cheng, Qian, et al.
Publicado: (2017)

Chaperone assisted recombinant expression of a mycobacterial aminoacylase in Vibrio natriegens and Escherichia coli capable of N-lauroyl-L-amino acid synthesis
por: Haeger, Gerrit, et al.
Publicado: (2023)

Serum aminoacylase-1 is a novel biomarker with potential prognostic utility for long-term outcome in patients with delayed graft function following renal transplantation
por: Welberry Smith, Matthew P, et al.
Publicado: (2013)

Aminoacylase 1 (ACY-1) Mediates the Proliferation and Migration of Neuroblastoma Cells in Humans Through the ERK/Transforming Growth Factor β (TGF-β) Signaling Pathways
por: Chen, Zimin, et al.
Publicado: (2021)

A Surgical Perspective on Targeted Therapy of Hepatocellular Carcinoma
por: Faltermeier, Claire, et al.
Publicado: (2015)

Identification of multiple substrate binding sites in SLC4 transporters in the outward-facing conformation: Insights into the transport mechanism
por: Zhekova, Hristina R., et al.
Publicado: (2021)

Effects of Clinical and Tumor Characteristics on Survival in Patients with Hepatocellular Carcinoma with Bone Metastasis
por: Ozer, Muhammet, et al.
Publicado: (2023)

Expression of Hypoxic Marker Carbonic Anhydrase IX Predicts Poor Prognosis in Resectable Hepatocellular Carcinoma
por: Huang, Wei-Ju, et al.
Publicado: (2015)

Tumor markers for hepatocellular carcinoma
por: ZHAO, YAN-JIE, et al.
Publicado: (2013)

Proteomic-Based Biosignatures in Breast Cancer Classification and Prediction of Therapeutic Response
por: He, Jianbo, et al.
Publicado: (2011)

The Number of Positive Tumor Marker Status Is Beneficial for the Selection of Therapeutic Modalities in Patients with Hepatocellular Carcinoma
por: Beppu, Toru, et al.
Publicado: (2017)

Cuentos para niños/
por: Pushkin, Alexánder

Habitante del otoño /
por: Pushkin, Alexander
Publicado: (1999)

Galad Score as a Prognostic Marker for Patients with Hepatocellular Carcinoma
por: Cagnin, Silvia, et al.
Publicado: (2023)

Cholesteryl Esters Are Elevated in the Lipid Fraction of Bronchoalveolar Lavage Fluid Collected from Pediatric Cystic Fibrosis Patients
por: Ma, Daniel C., et al.
Publicado: (2015)

Hepatocellular Carcinoma: Tumorigenesis and Prediction Markers
por: Braicu, Cornelia, et al.
Publicado: (2009)

Identification of PAFAH1B3 as Candidate Prognosis Marker and Potential Therapeutic Target for Hepatocellular Carcinoma
por: Xu, Weikang, et al.
Publicado: (2021)

Lipidomic Profiling of Mastoid Bone and Tissue from Patients with Chronic Otomastoiditis
por: Fazlollahi, Farbod, et al.
Publicado: (2014)

DLC-1 is an independent prognostic marker and potential therapeutic target in hepatocellular cancer
por: Song, L. J., et al.
Publicado: (2016)

ATAD2 as a Poor Prognostic Marker for Hepatocellular Carcinoma after Curative Resection
por: Hwang, Hye Won, et al.
Publicado: (2015)

Diagnostic and Prognostic Molecular Markers in Hepatocellular Carcinoma
por: Mínguez, Beatriz, et al.
Publicado: (2011)

Cancer stem cells in hepatocellular carcinomas
por: Das, Prasenjit, et al.
Publicado: (2015)

The therapeutic properties of resminostat for hepatocellular carcinoma
por: Zhao, Jun, et al.
Publicado: (2018)

“Complimenting the Complement”: Mechanistic Insights and Opportunities for Therapeutics in Hepatocellular Carcinoma
por: Malik, Astha, et al.
Publicado: (2021)

Evolving neural network optimization of cholesteryl ester separation by reversed-phase HPLC
por: Jansen, Michael A., et al.
Publicado: (2010)

Noninvasive Fibrosis Marker Can Predict Recurrence of Hepatocellular Carcinoma after Radiofrequency Ablation
por: Chung, Hyun Ah, et al.
Publicado: (2016)

Proximal renal tubular acidosis mediated by mutations in NBCe1-A: unraveling the transporter's structure-functional properties
por: Kurtz, Ira, et al.
Publicado: (2013)

Circulating miR‐130b‐ and miR‐21‐based diagnostic markers and therapeutic targets for hepatocellular carcinoma
por: Zhang, Nannan, et al.
Publicado: (2019)

Identification of Mutation Landscape and Immune Cell Component for Liver Hepatocellular Carcinoma Highlights Potential Therapeutic Targets and Prognostic Markers
por: Wang, Hengzhen, et al.
Publicado: (2021)

DLAT is a promising prognostic marker and therapeutic target for hepatocellular carcinoma: a comprehensive study based on public databases
por: Zhang, Peng, et al.
Publicado: (2023)

Serum thioredoxin is a diagnostic marker for hepatocellular carcinoma
por: Li, Jun, et al.
Publicado: (2015)

Cellular prognostic markers in hepatitis-related hepatocellular carcinoma
por: Petrizzo, A., et al.
Publicado: (2018)

KCNK levels are prognostic and diagnostic markers for hepatocellular carcinoma
por: Li, Wen-Chao, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ldptf087r71egcjf5vnf28vndo